Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Telomere dynamics in dyskeratosis congenita: the long and the short of iPS.

Literature DB >> 21788988

Telomere dynamics in dyskeratosis congenita: the long and the short of iPS.

Suneet Agarwal¹, George Q Daley.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2011 PMID： 21788988 PMCID： PMC3193482 DOI： 10.1038/cr.2011.120

Source DB: PubMed Journal: Cell Res ISSN： 1001-0602 Impact factor: 25.617

× No keyword cloud information.

15 in total

1. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors: L HAYFLICK
Journal: Exp Cell Res Date: 1965-03 Impact factor: 3.905

2. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.

Authors: Judy M Y Wong; Kathleen Collins
Journal: Genes Dev Date: 2006-10-02 Impact factor: 11.361

3. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming.

Authors: H Vaziri; K B Chapman; A Guigova; J Teichroeb; M D Lacher; H Sternberg; I Singec; L Briggs; J Wheeler; J Sampathkumar; R Gonzalez; D Larocca; J Murai; E Snyder; W H Andrews; W D Funk; M D West
Journal: Regen Med Date: 2010-05 Impact factor: 3.806

4. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells.

Authors: R P Lanza; J B Cibelli; C Blackwell; V J Cristofalo; M K Francis; G M Baerlocher; J Mak; M Schertzer; E A Chavez; N Sawyer; P M Lansdorp; M D West
Journal: Science Date: 2000-04-28 Impact factor: 47.728

5. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.

Authors: Andrew S Venteicher; Eladio B Abreu; Zhaojing Meng; Kelly E McCann; Rebecca M Terns; Timothy D Veenstra; Michael P Terns; Steven E Artandi
Journal: Science Date: 2009-01-30 Impact factor: 47.728

Review 6. Telomere diseases.

Authors: Rodrigo T Calado; Neal S Young
Journal: N Engl J Med Date: 2009-12-10 Impact factor: 91.245

7. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors: Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal: Cell Date: 2007-11-30 Impact factor: 41.582

8. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients.

Authors: Suneet Agarwal; Yuin-Han Loh; Erin M McLoughlin; Junjiu Huang; In-Hyun Park; Justine D Miller; Hongguang Huo; Maja Okuka; Rosana Maria Dos Reis; Sabine Loewer; Huck-Hui Ng; David L Keefe; Frederick D Goldman; Aloysius J Klingelhutz; Lin Liu; George Q Daley
Journal: Nature Date: 2010-02-17 Impact factor: 49.962

9. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.

Authors: Luis F Z Batista; Matthew F Pech; Franklin L Zhong; Ha Nam Nguyen; Kathleen T Xie; Arthur J Zaug; Sharon M Crary; Jinkuk Choi; Vittorio Sebastiano; Athena Cherry; Neelam Giri; Marius Wernig; Blanche P Alter; Thomas R Cech; Sharon A Savage; Renee A Reijo Pera; Steven E Artandi
Journal: Nature Date: 2011-05-22 Impact factor: 49.962

10. Telomere dynamics in human cells reprogrammed to pluripotency.

Authors: Steven T Suhr; Eun Ah Chang; Ramon M Rodriguez; Kai Wang; Pablo J Ross; Zeki Beyhan; Shashanka Murthy; Jose B Cibelli
Journal: PLoS One Date: 2009-12-02 Impact factor: 3.240

10 in total

Review 1. Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors: Ganna Bilousova; Dennis R Roop
Journal: Cold Spring Harb Perspect Med Date: 2014-11-03 Impact factor: 6.915

2. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors: Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal: Cell Res Date: 2011-12-20 Impact factor: 25.617

Review 3. Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering.

Authors: Moonjung Jung; Cynthia E Dunbar; Thomas Winkler
Journal: Mol Ther Date: 2015-10-05 Impact factor: 11.454

4. Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling.

Authors: Hinh Ly
Journal: World J Stem Cells Date: 2011-10-26 Impact factor: 5.326

5. Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs.

Authors: Thomas Winkler; So Gun Hong; Jake E Decker; Mary J Morgan; Chuanfeng Wu; William M Hughes; Yanqin Yang; Danny Wangsa; Hesed M Padilla-Nash; Thomas Ried; Neal S Young; Cynthia E Dunbar; Rodrigo T Calado
Journal: J Clin Invest Date: 2013-04-15 Impact factor: 14.808

Review 6. New lessons learned from disease modeling with induced pluripotent stem cells.

Authors: Tamer T Onder; George Q Daley
Journal: Curr Opin Genet Dev Date: 2012-06-28 Impact factor: 5.578

Review 7. The promise of induced pluripotent stem cells in research and therapy.

Authors: Daisy A Robinton; George Q Daley
Journal: Nature Date: 2012-01-18 Impact factor: 49.962

8. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.

Authors: Xiangjin Kang; Qian Yu; Yuling Huang; Bing Song; Yaoyong Chen; Xingcheng Gao; Wenyin He; Xiaofang Sun; Yong Fan
Journal: PLoS One Date: 2015-07-01 Impact factor: 3.240

Review 9. Quality control: Genome maintenance in pluripotent stem cells.

Authors: Uri Weissbein; Nissim Benvenisty; Uri Ben-David
Journal: J Cell Biol Date: 2014-01-20 Impact factor: 10.539

10. Influences of lamin A levels on induction of pluripotent stem cells.

Authors: Bingfeng Zuo; Jiao Yang; Fang Wang; Lei Wang; Yu Yin; Jiameng Dan; Na Liu; Lin Liu
Journal: Biol Open Date: 2012-09-07 Impact factor: 2.422

10 in total